-
<![CDATA[Clinical and Economic Considerations for Nivolumab-Based Therapy for Resectable Non–Small Cell Lung Cancer]]>
13 Nov 2025 06:10 GMT
This clinical brief is sponsored by Bristol Myers Squibb and is intended for payers, formulary committees, or other similar individuals or entities with knowledge and expertise in the area of health care economic analysis carrying out responsibilities for …
-
Outcomes in Extensive-Stage Small Cell Lung Cancer Treatment
12 Nov 2025 22:14 GMT
… extensive-stage small cell lung cancer (ES-SCLC) remains one … extensive-stage small cell lung cancer. This research … 03408-z
Keywords:
Small Cell Lung Cancer, Chemotherapy, Treatment … of lung cancer therapiesextensive-stage small cell lung cancer treatmentfirst …
-
<![CDATA[Intracranial activity of ifinatamab deruxtecan (I-DXd) in patients with extensive-stage small cell lung cancer and baseline brain metastases: Primary analysis of IDeate-Lung01]]>
12 Nov 2025 17:21 GMT
… ) in patients with extensive-stage small cell lung cancer (ES-SCLC), including those with baseline … with relapsed or refractory ES-SCLC.
-
Non-Small Cell Lung Cancer Therapeutics Market to Reach US$ 64.92 Billion by 2033 | Datam Intelligence
12 Nov 2025 13:38 GMT
… #47;non-small-cell-lung-cancer-therapeutics-market … small-cell-lung-cancer-therapeutics-market
Market Drivers:
✅ Rising Lung Cancer … report=non-small-cell-lung-cancer-therapeutics- … Non-Small Cell Lung Cancer Therapeutics Market
lung cancer therapeutics …
-
Five Truths about Lung Cancer
12 Nov 2025 19:05 GMT
… to complete; Lung cancer screening is … eligible for lung cancer screenings … of lung cancer: Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). … Both are treated very differently. About 80-85% of lung cancers …
-
The Intricate Web of MicroRNAs in Modulating EGFR-TKI Resistance in Non-Small Cell Lung Cancer: A Comprehensive Review
11 Nov 2025 07:13 GMT
… subset of non-small cell lung cancer (NSCLC) patients, … mutation-positive non-small-cell lung cancer (FURLONG): a multicentre … resistance in non-small cell lung cancer via increasing AXL … T790M-positive non-small cell lung cancer. Transl Lung Cancer Res. 2022 …
-
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
11 Nov 2025 07:00 GMT
… of extensive stage small cell lung cancer (ES-SCLC) and Merkle Cell … in patients with ES-SCLC treated with checkpoint inhibitors … neuroendocrine cancers, including ES-SCLC and MCC. Dosing … for extensive stage small cell lung cancer (ES-SCLC) and Merkel Cell …
-
<![CDATA[Ifinatamab Deruxtecan Development Continues in Phase 3 Study After Robust Results in Pretreated ES-SCLC ]]>
13 Nov 2025 03:20 GMT
… patients with extensive-stage small cell lung cancer (ES-SCLC), according to findings … subjects with extensive stage-small cell lung cancer (IDeate-Lung03). Clinicaltrials.gov … ) with extensive-stage small cell lung cancer (ES-SCLC): primary results of the …
-
Wellness Wednesday: Catching lung cancer early can save lives
12 Nov 2025 01:55 GMT
… cause of lung cancer, responsible for about 85% of lung cancer deaths.
But … and could be lifesaving.
When lung cancer is found early, treatment options … 87% of lung cancers are non-small cell lung cancer, while about 13% are small cell lung cancer. Your …
-
Pharmac To Fund Five Medicines For Multiple Sclerosis, Breast Cancer, Eye Conditions, And Lung Cancer
12 Nov 2025 01:12 GMT
… breast cancer, eye conditions, and lung cancer will benefit from five medicines … people with ROS1-positive non-small cell lung cancer.
Bevacizumab (Avastin) – secured ongoing … funding for faricimab (Vabysmo) and lung cancer treatments. It will use this …
About
© 1995-2025